喘恶化并发症指数 (AECI):预测住院不良结果
Chongyang Zhao1, Lei Wang2, Li Zhang2
1Department of Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, China; Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, China.
Respiratory medicine
|March 5, 2025
概括
伴随性疾病显著恶化了喘恶化患者的结果. 新的喘恶化并发症指数 (AECI) 工具有助于识别高风险个体,以便做出更好的临床决策.
科学领域:
- 肺部医学 肺部医学
- 临床流行病学临床流行病学
- 医疗保健管理的管理
背景情况:
- 喘恶化 (AE) 可以导致严重的后果,包括死亡,尽管最佳治疗.
- 伴随性疾病在喘患者中很普遍,影响生活质量,医疗保健利用率和治疗成功率.
- 目前还没有一个全面的工具来评估和管理AE期间的并发症.
研究的目的:
- 评估患有AEs的患者在医院内与并发症相关的综合结局的风险.
- 开发和验证一种预测工具,即喘恶化并发症指数 (AECI),用于风险分层.
主要方法:
- 实践中对AEs的住院患者进行了一项实践研究.
- 综合结局 (死亡,ICU入院,侵入性通风) 的风险与个别并发症,并发症系统和并发症总数相对应.
- 喘恶化并发症指数 (AECI) 是通过结合主要已识别的并发症而开发的.
主要成果:
- 在43种评估的并发症中,有9种与复合结果有显著联系.
- 每个额外的并发症都会使综合结局风险增加25% (P < 0.001).
- 该AECI显示AUC为75.98%,一个点的增加与复合结果风险增加0.51倍相关 (P<0.001).
结论:
- 在AE患者中,高的并发症患病率与预后较差相关.
- AECI是评估AE患者的并发病症的一个有价值的工具.
- 该AECI使临床医生能够识别高风险的住院患者,并为治疗决策提供信息.
相关概念视频
Asthma-III: Symptoms and Complications
2.4K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.4K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
2.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
2.9K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170


